Assessment of Actual Dose Adjustment in Patients Switching From Intravenous Immunoglobulin (IGIV) Therapy to IGSC 20%

被引：0
|
作者：
Luo, M. [1 ]
Iyer, R. [1 ]
Li-McLeod, J. [1 ]
机构：
[1] Baxter Healthcare Corp, Deerfield, IL 60015 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2012年 / 129卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2011.12.540
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB110 / AB110
页数：1
相关论文
共 50 条
  • [21] Acute Hemolysis After High-Dose Intravenous Immunoglobulin Therapy in Highly HLA Sensitized Patients
    Kahwaji, Joseph
    Barker, Eva
    Pepkowitz, Sam
    Klapper, Ellen
    Villicana, Rafael
    Peng, Alice
    Chang, Robert
    Jordan, Stanley C.
    Vo, Ashley A.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (12): : 1993 - 1997
  • [22] Switching from subcutaneous to intravenous erythropoietin α in haemodialysis patients requires a major dose increase
    Galliford, JW
    Malasana, R
    Farrington, K
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (09) : 1956 - 1962
  • [23] High-dose intravenous immunoglobulin pulse therapy in patients with progressive immunoglobulin A nephropathy:: a long-term follow-up
    Rasche, F. M.
    Keller, F.
    Lepper, P. M.
    Aymanns, C.
    Karges, W.
    Sailer, L. -C.
    von Mueller, L.
    Czock, D.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 146 (01): : 47 - 53
  • [24] Association of hemolysis with high dose intravenous immunoglobulin therapy in pediatric patients: An open-label prospective trial
    Akman, Alkim Oden
    Kara, Fatma Karaca
    Koksal, Tulin
    Cakir, Bahar Cuhaci
    Karagol, Cuneyt
    Sayli, Tulin
    TRANSFUSION AND APHERESIS SCIENCE, 2017, 56 (04) : 531 - 534
  • [25] Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis
    Saito, Eizo
    Koike, Takao
    Hashimoto, Hiroshi
    Miyasaka, Nobuyuki
    Ikeda, Yasuo
    Hara, Masako
    Yamada, Hidehiro
    Yoshida, Tadashi
    Harigai, Masayoshi
    Ichikawa, Yoichi
    MODERN RHEUMATOLOGY, 2008, 18 (01) : 34 - 44
  • [26] Dose of epoetin alfa used in haemodialysis patients when switching from subcutaneous to intravenous administration
    Pussell, Bruce A.
    Walker, Rowan
    NEPHROLOGY, 2007, 12 (02) : 120 - 125
  • [27] Flat Dose Intravenous Immunoglobulin Primary Infection Prophylaxis in Multiple Myeloma Patients on Bispecific Antibody Therapy: Vanderbilt Experience
    Marneni, Naimisha
    Dholaria, Bhagirathbhai
    Sengsayadeth, Salyka
    Biltibo, Eden Ayele
    Patel, Vivek
    Bhaskar, Shakthi
    Jayani, Reena
    Gilbert, Jill
    Berlin, Jordan
    Kishtagari, Ashwin
    Mohan, Sanjay
    Morgan, David
    Oluwole, Olalekan O.
    Savani, Bipin N.
    Kassim, Adetola A.
    Baljevic, Muhamed
    BLOOD, 2023, 142
  • [28] Immunomodulatory effect of IgM/IgA-enriched high dose intravenous immunoglobulin therapy in COVID-19 patients
    Basta, Milan
    Tomic, Sergej
    Ilic, Natasa
    Bekic, Marina
    Glamoclija, Sofija
    Karan, Radmila
    Kostic, Natasa Kovacevic
    Dimic, Nemanja
    Djuric, Marko
    Nenadic, Irina
    Bobnos, Marina
    Bojic, Suzana
    Ljubojevic, Aleksandra
    Ignjatovic, Duska
    Djukanovic, Marija
    Velickovic, Jelena
    Cazic, Marija
    Jankovic, Srdja
    Stevanovic, Predrag
    Milosavljevic, Ljiljana Sofronic
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 111 - 111
  • [29] Switching from Intravenous to Subcutaneous Biological Therapy for Inflammatory Bowel Disease Patients Remains a Challenge
    Richter, Vered
    Cohen, Daniel L.
    Kriger-Sharabi, Ofra
    Zelnik Yovel, Dana
    Kochen, Nadav
    Broide, Efrat
    Shirin, Haim
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (05)
  • [30] Impact of switching from intravenous to oral linezolid therapy in Japanese patients: A retrospective cohort study
    Tanaka A.
    Yano A.
    Watanabe S.
    Tanaka M.
    Araki H.
    Journal of Pharmaceutical Policy and Practice, 9 (1)
12345